Drugs News and Research

RSS

Powerful antimicrobial molecules engineered from toxic proteins in wasp venom

A team led by scientists in the Perelman School of Medicine at the University of Pennsylvania has engineered powerful new antimicrobial molecules from toxic proteins found in wasp venom.

12 Oct 2020

Dopamine and serotonin play role in perception and decision-making

Scientists at Wake Forest School of Medicine have recorded real time changes in dopamine and serotonin levels in the human brain that are involved with perception and decision-making.

12 Oct 2020

New study reports on extremely potent human monoclonal antibodies for SARS-CoV-2

Researchers have recovered and identified the various types of neutralizing antibodies for SARS-CoV-2 from convalescent COVID-19 patients. Of these, they identified three that are extremely potent and could be used to develop treatment therapies.

11 Oct 2020

Analysis of existing comorbidities and COVID-19 mortality

As the COVID-19 pandemic continues to spread, and research related to potential risk factors for COVID-19 mortality continues, it is becoming clear that individuals with underlying comorbidities have a greater risk of death from COVID-19. The exact contribution of different comorbidities is unclear, however. Now, a new study published in the journal PLOS ONE dissects this topic and may help to quantify the risk posed by specific conditions and offer help with the prognosis.

11 Oct 2020

Chemists suggest a new domino reaction to produce organic compounds against cancers

A team of chemists from RUDN University suggested a new reaction to produce organic compounds in one vessel.

9 Oct 2020

Study shows unique cardioprotective properties of an old drug

A drug costing less than 2 euros per dose could reduce the long term consequences of a heart attack, benefitting millions of patients. Metoprolol, a member of the beta-blocker class of drugs that has been in use for more than 40 years, has been found to have unique cardioprotective properties.

9 Oct 2020

Developing a precision 'Trojan Horse' nanotherapy to treat breast cancer

With a nearly $2.6 million grant from the National Institutes of Health, Michigan State University researchers are using nanoscopic particles to turn the body's own cells into weapons that cancer won't see coming.

9 Oct 2020

Study compares the effect of hydroxychloroquine versus favipiravir in SARS-CoV-2−infected hamsters

Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters.

9 Oct 2020

Exuberant activation of immune cells in severe COVID-19 resembles lupus

In severe cases of COVID-19, Emory researchers have been observing an exuberant activation of immune cells, resembling acute flares of systemic lupus erythematosus (SLE), an autoimmune disease.

9 Oct 2020

Researchers develop international policy index for HIV prevention among drug users

Peter Meylakhs, from HSE University - St. Petersburg, together with colleagues from Georgia State University (USA) and Tarbiat Modares University (Tehran), have developed the HIV-PWID Policy Index (HPPI)--an international policy index for HIV prevention among people who inject drugs.

9 Oct 2020

As Trump touts his ‘great’ COVID drugs, the pharma cash flows to Biden, not him

Pharmaceutical giants Regeneron and Gilead Sciences got the kind of publicity money can't buy this week after President Donald Trump took their experimental drugs for his coronavirus infection, left the hospital and pronounced himself fully recovered.

9 Oct 2020

BioChromato's Smart Evaporator C1 offers safe, efficient concentration of low volume samples

BioChromato Inc. reports how the Department of Bioimaging Information Analysis at Gunma University is benefiting from the ability of its Smart Evaporator C1 to safely and efficiently concentrate low volume samples.

From BioChromato Inc. 9 Oct 2020

New drug delivery systems can improve treatment for diseases that affect connective tissues

University of Delaware Professor Kristi Kiick is leading collaborative research to create new drug delivery systems with the potential to improve treatment for diseases that affect connective tissues, such as osteoarthritis or rheumatoid arthritis, which is an autoimmune disease.

9 Oct 2020

Neurobiologists decode central mechanism of degenerative processes in brains of mouse models

Heidelberg neurobiologists decode central mechanism of degenerative processes in the brains of mouse models and develop new principle for therapeutic agents

9 Oct 2020

Transplantation of pig hearts may solve chronic shortage of donor organs

The goal of harvesting hearts from pigs to solve the chronic shortage of these donor organs appears to be in reach, according to a new scientific review by researchers at Massachusetts General Hospital (MGH).

9 Oct 2020

Survey: More Americans trust Biden to efficiently lead U.S. healthcare system through COVID-19

With Election Day less than a month away, a new West Health-Gallup national survey finds more Americans trust former Vice President Joe Biden than President Donald Trump to efficiently lead the U.S. healthcare system through the COVID-19 pandemic.

8 Oct 2020

Novel radioimmunotherapy proven effective in reversing resistance to lymphoma therapy

A new radioimmunotherapy has proven effective in reversing resistance to the most commonly used lymphoma drug, rituximab, according to research published in the October issue of The Journal of Nuclear Medicine.

8 Oct 2020

Research uncovers a novel way of preventing or treating epilepsy

Epileptic seizures often originate in small, localized areas of the brain where neurons abnormally fire in unison.

8 Oct 2020

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

Today, the U.S. Food and Drug Administration announced that it has awarded six new clinical trial research grants to principal investigators from academia and industry totaling over $16 million over the next four years.

8 Oct 2020

Using mRNA therapies or CRISPR gene editing to treat cystic fibrosis

The potential for treating cystic fibrosis (CF) using mRNA therapies or CRISPR gene editing is possible regardless of the causative mutation. CF clinical trials showing that a genotype-agnostic gene therapy for CF is possible are reviewed in the peer-reviewed journal Human Gene Therapy.

8 Oct 2020

Drugs News and Research

Powerful antimicrobial molecules engineered from toxic proteins in wasp venom

Dopamine and serotonin play role in perception and decision-making

New study reports on extremely potent human monoclonal antibodies for SARS-CoV-2

Analysis of existing comorbidities and COVID-19 mortality

Chemists suggest a new domino reaction to produce organic compounds against cancers

Study shows unique cardioprotective properties of an old drug

Developing a precision 'Trojan Horse' nanotherapy to treat breast cancer

Study compares the effect of hydroxychloroquine versus favipiravir in SARS-CoV-2−infected hamsters

Exuberant activation of immune cells in severe COVID-19 resembles lupus

Researchers develop international policy index for HIV prevention among drug users

As Trump touts his ‘great’ COVID drugs, the pharma cash flows to Biden, not him

BioChromato's Smart Evaporator C1 offers safe, efficient concentration of low volume samples

New drug delivery systems can improve treatment for diseases that affect connective tissues

Neurobiologists decode central mechanism of degenerative processes in brains of mouse models

Transplantation of pig hearts may solve chronic shortage of donor organs

Survey: More Americans trust Biden to efficiently lead U.S. healthcare system through COVID-19

Novel radioimmunotherapy proven effective in reversing resistance to lymphoma therapy

Research uncovers a novel way of preventing or treating epilepsy

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

Using mRNA therapies or CRISPR gene editing to treat cystic fibrosis

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News